Forrester Announces Full Agenda For CX Summit EMEA 2025
Forrester (Nasdaq: FORR) today announced the full conference agenda for its CX Summit EMEA event, scheduled to take place in London and digitally on June 2–4, 2025. In today's competitive market, customers expect consistent and personalised experiences across every interaction. To meet these expectations, leaders must focus on several key initiatives, including delivering data-driven personalisation, implementing effective measurement tools, and leveraging technology to drive meaningful engagement throughout the entire customer lifecycle.
This year's event theme, 'The Total Experience: Your Brand, Their Journey,' delivers innovative insights and practical tools to help customer experience (CX), B2C marketing, and digital leaders build a comprehensive CX strategy that not only drives customer satisfaction and loyalty but also contributes to increased revenue and brand reputation. Attendees at CX Summit EMEA will gain valuable insights through keynote presentations, case studies, and interactive breakout sessions.
Featuring the latest research themes and frameworks, noteworthy keynotes and sessions include:
Brand + CX Powers Growth. This keynote unveils Forrester's total experience score: a new measurement framework that evaluates both brand and customer experience. Attendees will learn how an integrated strategy can increase revenue up to 3.5x.
Design For The Future Of Experiences. This keynote explores how digital experiences are evolving to become more humanlike, intuitive, and empowering. Attendees will discover practical tools to build their own capabilities for delivering advanced customer experiences.
Navigate The Culture Risks Of Metrics. In this keynote, attendees will hear how metrics shape organisational culture and behaviours, identify and address harmful measurement practices, and learn how to strategically build a culture that aligns with business goals for sustained growth.
Lead And Master Change. This keynote details how leaders can elevate their change leadership skills and provides strategies to survive and thrive in a state of continuous disruption and transformation.
Build Customer Trust In AI. In this session, attendees will learn what drives customer trust in AI, gain insights from successful AI implementations, and discover how to integrate trustworthy practices into their AI strategies.
'Aligning brand and customer experience empowers businesses to build trust, enhance loyalty, and drive revenue growth,' said Martin Gill, VP and research director at Forrester. 'However, this is an endeavour that requires a holistic approach: fostering collaboration across departments, delivering consistent interactions that inspire trust and loyalty, and balancing data insights with human touch. CX Summit EMEA will equip attendees with the capabilities, tools, and actionable insights to deliver experiences that optimise the entire customer lifecycle.'
The event also features unique workshops and tailored programmes to engage attendees in hands-on learning, including the Executive Leadership Exchange, an invitation-only programme for CX executives; the Forrester Women's Leadership Programme, focused on empowering women in leadership roles; and interactive sessions on CX certification and skill building.
In addition, CX Summit EMEA will honour the recipient of Forrester's 2025 Customer-Obsessed Enterprise Award for EMEA, which recognises companies that drive business success by putting customers at the centre of their leadership strategy and operations.
About Forrester
Forrester (Nasdaq: FORR) is one of the most influential research and advisory firms in the world. We empower leaders in technology, customer experience, digital, marketing, sales, and product functions to be bold at work and accelerate growth through customer obsession. Our unique research and continuous guidance model helps executives and their teams achieve their initiatives and outcomes faster and with confidence. To learn more, visit Forrester.com.
SOURCE: Forrester
Copyright Business Wire 2025.
PUB: 03/03/2025 05:00 AM/DISC: 03/03/2025 05:00 AM
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
Is Nvidia stock a massive bargain — or a massive value trap?
AI has transformed demand for computer chips and the most obvious beneficiary of that has been Nvidia (NASDAQ: NVDA). With a stock market capitalization of $3.4trn, Nvidia might not seem like an obvious bargain. But what if it is really worth that much – or potentially a lot more? I have been keen to add some Nvidia stock to my portfolio, but I do not want to overpay. After all, Nvidia has shot up 1,499% in five years! So, here is what I am doing. For some companies in which I have invested in the past, from Reckitt to Burberry, I have benefited as an investor from a market being mature. Sales of detergent or pricy trenchcoats may grow over time, but they are unlikely to shoot up year after year. That is because those firms operate in mature markets. On top of that, as they are large and long-established, it is hard for them to grow by gaining substantial market share. So, market maturity has helped me as an investor because it has made it easier for me to judge what I think the total size of a market for a product or service may be – and how much of it the company in question looks likely to have in future. Chips, by contrast, are different. Even before AI, this was still a fast-growing industry – and AI has added fuel to that fire. On top of that, Nvidia is something of a rarity. It is already a large company and generated $130bn in revenues last year. But it is not mature – rather, it continues to grow at a breathtaking pace. Its first-quarter revenue was 69% higher than in the same three months of last year. Those factors mean that it is hard to tell what Nvidia is worth. Clearly that is not only my opinion: the fact that Nvidia stock is 47% higher than in April suggests that the wider market is wrestling with the same problem. Could it be a value trap? It is possible. For example, chip demand could fall after the surge of recent years and settle down again at a much lower level. A lower cost rival could eat badly into Nvidia's market share. Trade disputes could see sales volumes fall. With a price-to-earnings (P/E) ratio of 46, just a few things like that going wrong could mean today's Nvidia stock price ends up looking like a value trap. On the other hand, think about those first-quarter growth rates. If Nvidia keeps doing as well, let alone better, its earnings could soar. In that case, the prospective P/E ratio based on today's share price could be low and the current share price a long-term bargain. I see multiple possible drivers for such an increase, such as more widespread adoption of AI and Nvidia launching even more advanced proprietary chip designs. So, I reckon the company could turn out to be either a massive bargain at today's price, or a massive value trap. The price does not offer me enough margin of safety for my comfort if the stock is indeed a value trap. So, I will wait for a more attractive valuation before buying. The post Is Nvidia stock a massive bargain — or a massive value trap? appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool C Ruane has no position in any of the shares mentioned. The Motley Fool UK has recommended Burberry Group Plc, Nvidia, and Reckitt Benckiser Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025
Forbes
an hour ago
- Forbes
Is Lululemon's Recent Pullback Your Perfect Entry Point?
CHINA - 2025/04/17: A shopper walks past the Canadian sportswear clothing band Lululemon store. ... More (Photo by Sebastian Ng/SOPA Images/LightRocket via Getty Images) Lululemon stock (NASDAQ:LULU) is currently trading at approximately $331 and seems undervalued based on its strong fundamentals, even though the stock often experiences volatility during turbulent market conditions. The company provided impressive Q1 2025 results, with revenue increasing by 7% to $2.37 billion and EPS rising to $2.60, just surpassing expectations. However, the market concentrated on a weaker-than-anticipated 1% increase in same-store sales and a revised full-year outlook, influenced in part by tariff-related pressures. The consequence? A swift 22% decline in after-hours trading that reflects more about short-term market sentiment than long-term intrinsic value. In spite of its high-performance profile, LULU behaves like a value stock. Lululemon trades at about 18x its trailing earnings (slightly lower than the historical average) and 19x price-to-free cash flow – both figures are beneath the S&P 500's averages—yet it is a company that consistently excels in revenue, margins, and return on capital. In comparison with its main competitor Nike, Lululemon is more affordable across significant profit metrics, with a reduced P/E and a more appealing P/FCF ratio. Investors are essentially acquiring Ferrari performance at Lexus pricing. Moreover, with a $32 billion market cap generating $1.6 billion in trailing free cash flow—a 5% cash flow yield, LULU appears to be more of a long-term wealth builder than a fluctuating apparel brand. For those looking for lower volatility compared to individual stocks, the Trefis High Quality portfolio offers an alternative – having outperformed the S&P 500 and yielding returns exceeding 91% since inception. Lululemon continues to showcase its growth capabilities. The company reports an impressive three-year revenue CAGR of 19%, which is more than three times the S&P 500's 5.5%. Over just the past year, it demonstrated 10% revenue growth, increasing annual sales to about $11 billion. Despite encountering macroeconomic challenges, the brand persists as a global growth powerhouse with an expanding international presence and remarkable efficiency. Its operating margin over the last four quarters of 23.7% nearly doubles the S&P 500's 13.2%, while its operating cash flow and net income margins (21.5% and 17.1%, respectively) significantly outperform broader market averages. These figures are not merely good—they're elite. Lululemon's balance sheet resembles a fortress. With a debt-to-equity ratio of just 4.9%, it is significantly below the S&P 500 average of 19.9%. Additionally, its cash-to-assets ratio of 26.1% far exceeds the market's 13.8%. This immaculate financial status provides Lululemon with both strength during downturns and the ability to invest in further growth. There's no way to sugarcoat it: Lululemon has experienced dramatic declines during market corrections. It dropped 46% during the downturn of 2022 (compared to the S&P's 25%), fell 47% in the early 2020 COVID-19 shock (versus 34%), and was extremely affected during the 2008 crash, plummeting 92% (compared to 57%). Investors must recognize that with LULU, strong fundamentals don't necessarily provide protection against sharp changes in sentiment. Our dashboard How Low Can Stocks Go During A Market Crash illustrates how major stocks performed during and after the last six market crashes. Lululemon checks nearly every box: strong growth, solid profitability, and a fortified balance sheet, with the only drawback being its susceptibility during market downturns. Trading at a slight discount relative to its strong performance profile, the recent Q1 results, which included mixed outcomes and cautious guidance, underscore immediate challenges while preserving the integrity of long-term fundamentals. Nonetheless, you could also consider the Trefis Reinforced Value (RV) Portfolio, which has surpassed its all-cap stocks benchmark (a combination of the S&P 500, S&P mid-cap, and Russell 2000 benchmark indices) to yield strong returns for investors. Why is that? The quarterly rebalanced mix of large-, mid- and small-cap RV Portfolio stocks offered a responsive strategy to capitalize on positive market conditions while limiting losses during downturns, as detailed in RV Portfolio performance metrics.
Associated Press
3 hours ago
- Associated Press
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Zenas To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of Zenas pursuant and/or traceable to Zenas' registration statement for the initial public offering held on or about September 13, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - June 8, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Zenas BioPharma, Inc. ('Zenas' or the 'Company') (NASDAQ: ZBIO) and reminds investors of the June 16, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. [ This image cannot be displayed. Please visit the source: ] Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Zenas BioPharma materially overstated the amount of time it would be able to fund its operations using existing cash and expected net proceeds from the IPO; and (2) as a result, defendants' public statements were materially false and misleading at all relevant times and negligently prepared. When the true details entered the market, the lawsuit claims that investors suffered damages. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Zenas' conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Zenas BioPharma class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. To view the source version of this press release, please visit
